Apollomics APLM
NASDAQ APLM
$18.60 +0.35 (+1.92%)
As of: Nov 10, 2026 · 1:27 PM EST

Apollomics (APLM) Payables (2023 - 2024)

Updated

Apollomics' Payables came in at $3.51 million for Q2 2024, up 270.4% from $947,000 a year earlier.

Analysis

Apollomics (APLM) Payables (2023 - 2024) Analysis & Trends

At the end of FY2023, Apollomics' Payables was $4.24 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 18.17 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 34.43 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.17 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 22.89 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 934.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 4.07 Bn
10 Apollomics 40.08 Mn -1.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.51 Mn
Dec 31, 2023 4.24 Mn
Jun 30, 2023 947,000.00
API Access

Apollomics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=APLM&period=max&api_key=YOUR_API_KEY